Evidence mapPaperPMID 42544342Full record

ArticlePsoriasis (Auckland, N.Z.)2026

Impact of Psoriasis on Patient Well-Being Across Life Stages: A Cross-Sectional Survey (Inpsight Working Group).

Esteban Daudén, Pablo De la Cueva, Isabel Belinchón, Fernando Gallardo, Pablo Coto, Ricardo Ruiz-Villaverde, José Luís Poveda, Esther Ramirez, Elena Colominas, Sandra Ros and 3 more

Abstract read
In one paragraph

Article in Psoriasis (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Esteban DaudénDepartamento de Dermatología, Hospital Universitario La Princesa, Madrid, Spain.
Pablo De la CuevaDepartamento de Dermatología, Hospital Universitario Infanta Leonor, Madrid, Spain.
Isabel BelinchónDepartamento de Dermatología, Hospital General Universitario Dr. Balmis, Alicante, Spain.
Fernando GallardoDepartamento de Dermatología, Hospital del Mar, Barcelona, Spain.ORCID 0000-0002-8996-3828
Pablo CotoDepartamento de Dermatología, Hospital Vital Álvarez Buylla, Asturias, Spain.
Ricardo Ruiz-VillaverdeDepartamento de Dermatología, Hospital Universitario San Cecilio, Granada, Spain.
José Luís PovedaDirección Hospitalaria, Hospital Universitario y Politécnico, Valencia, Spain.
Esther RamirezDepartamento de Farmacia Hospitalaria, Hospital Universitario La Princesa, Madrid, Spain.ORCID 0000-0003-3053-7426
Elena ColominasDepartamento de Farmacia Hospitalaria, Hospital del Mar, Barcelona, Spain.
Sandra RosDepartamento de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Santiago AlfonsoAcción Psoriasis Association, Barcelona, Spain.
Dámaris López-PérezOutcomes'10 (a ProductLife Group Company), Castellón de La Plana, Spain.ORCID 0009-0004-9785-9651
Marta ComellasOutcomes'10 (a ProductLife Group Company), Castellón de La Plana, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Psoriasis is a chronic disease with a multidimensional impact that extends beyond skin symptoms, affecting physical, emotional, social well-being and satisfaction with care. This study aims to explore the perceived self-reported impact of psoriasis on patients' well-being across different life stages and to identify risk and protective factors associated with well-being over time. Methods: A cross-sectional observational study was conducted using an electronic questionnaire administered to adult patients with psoriasis and healthcare professionals involved in psoriasis management. Patients retrospectively self-reported the perceived impact of psoriasis on overall well-being and its physical, emotional, social, and treatment-related domains across consecutive 10-year life stages. Both patients and healthcare professionals evaluated perceived risk and protective factors for well-being. Results: A total of 53 patients and 54 healthcare professionals completed the questionnaire. Most patients (90.6%) reported psoriasis had negatively affected their general well-being at some point during the disease course, with the physical (90.6%) and emotional (88.7%) domains being the most impacted. The highest perceived burden was reported between 31 and 40 years of age. Better reported symptom control was associated with lower perceived impairment in well-being. Key risk factors included affected body areas (95.3%), comorbidities (93.5%), and disease severity (89.7%), whereas appropriate treatment (96.3%), adequate medical care (93.5%), and a positive physician-patient relationship (89.7%) were identified as protective factors. Conclusion: These exploratory findings suggest that the self-reported perceived impact of psoriasis on well-being varies across life stages and is strongly influenced by symptom control and holistic disease management. These findings support a longitudinal, patient-centered approach to optimize long-term well-being.

Indexed as

consensuspsoriasiswell-being

Identifiers

PMID42544342
PMCPMC13429117

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.